{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:17:37Z","timestamp":1791137857370,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.bcp.2010.04.003","type":"journal-article","created":{"date-parts":[[2010,4,10]],"date-time":"2010-04-10T08:33:56Z","timestamp":1270888436000},"page":"602-612","source":"Crossref","is-referenced-by-count":77,"title":["The bone marrow microenvironment as a sanctuary for minimal residual disease in CML"],"prefix":"10.1016","volume":"80","author":[{"given":"Rajesh R.","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Tolentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Hazlehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.04.003_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","article-title":"Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia","volume":"306","author":"Bartram","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/306239a0","article-title":"Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia","volume":"306","author":"Heisterkamp","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/shem.2003.50034","article-title":"Molecular mechanisms of transformation by the BCR-ABL oncogene","volume":"40","author":"Sattler","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2007-07-103523","article-title":"Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment","volume":"111","author":"Hochhaus","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib10","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib11","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.leu.2403426","article-title":"Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance","volume":"18","author":"Hochhaus","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bcp.2010.04.003_bib13","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1182\/blood-2002-09-2790","article-title":"Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy","volume":"101","author":"Cortes","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2010.04.003_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.04.003_bib16","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL","volume":"354","author":"Kantarjian","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib17","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib18","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1182\/blood.V88.6.2267.bloodjournal8862267","article-title":"Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels","volume":"88","author":"Inoue","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01715137","article-title":"In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT","volume":"68","author":"Martin","year":"1994","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V46.1.65.65","article-title":"The relative spatial distributions of CFUs and CFUc in the normal mouse femur","volume":"46","author":"Lord","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/108497802760363204","article-title":"Structure and function of bone marrow hemopoiesis: mechanisms of response to ionizing radiation exposure","volume":"17","author":"Fliedner","year":"2002","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.bcp.2010.04.003_bib22","first-page":"249","article-title":"Structure and function of sinusoidal endothelium of bone marrow","volume":"59B","author":"Tavassoli","year":"1981","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib23","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V82.7.2031.2031","article-title":"The role of hypoxia in the maintenance of hematopoietic stem cells","volume":"82","author":"Cipolleschi","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib24","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1128\/MCB.23.24.9349-9360.2003","article-title":"Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing","volume":"23","author":"Scott","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.04.003_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1182\/blood-2004-09-3417","article-title":"VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin","volume":"106","author":"Ulyanova","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20041385","article-title":"Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist","volume":"201","author":"Broxmeyer","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib27","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1152\/ajplegacy.1959.197.6.1255","article-title":"Innervation of the vessels of the marrow cavity of certain bones","volume":"197","author":"Weiss","year":"1959","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bcp.2010.04.003_bib29","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2003-01-0318","article-title":"Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure","volume":"102","author":"Abkowitz","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib30","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1126\/science.1064081","article-title":"Physiological migration of hematopoietic stem and progenitor cells","volume":"294","author":"Wright","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.04.003_bib31","first-page":"119","article-title":"A comparative study of the repopulating potential of grafts from various haemopoietic sources: CFU repopulation","volume":"3","author":"Schofield","year":"1970","journal-title":"Cell Tissue Kinet"},{"key":"10.1016\/j.bcp.2010.04.003_bib32","first-page":"7","article-title":"The relationship between the spleen colony-forming cell and the haemopoietic stem cell","volume":"4","author":"Schofield","year":"1978","journal-title":"Blood Cells"},{"key":"10.1016\/j.bcp.2010.04.003_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbio.200910072","article-title":"In vivo imaging of hematopoietic stem cells and their microenvironment","volume":"2","author":"Lo Celso","year":"2009","journal-title":"J Biophotonics"},{"key":"10.1016\/j.bcp.2010.04.003_bib34","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.V97.8.2293","article-title":"Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches","volume":"97","author":"Nilsson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.stem.2007.06.001","article-title":"Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance","volume":"1","author":"Kiel","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcp.2010.04.003_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2004.07.004","article-title":"Tie2\/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche","volume":"118","author":"Arai","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.04.003_bib38","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","article-title":"Identification of the haematopoietic stem cell niche and control of the niche size","volume":"425","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib39","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood-2003-11-4011","article-title":"Hematopoiesis is severely altered in mice with an induced osteoblast deficiency","volume":"103","author":"Visnjic","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature04247","article-title":"Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor","volume":"439","author":"Adams","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib41","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2002-05-1344","article-title":"Hyaluronan is synthesized by primitive hemopoietic cells, participates in their lodgment at the endosteum following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro","volume":"101","author":"Nilsson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib42","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood-2004-01-0272","article-title":"G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow","volume":"106","author":"Semerad","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib43","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1084\/jem.20041992","article-title":"Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size","volume":"201","author":"Stier","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","article-title":"SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells","volume":"121","author":"Kiel","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.04.003_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri1202","article-title":"The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease","volume":"3","author":"Engel","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2010.04.003_bib46","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2010.04.003_bib47","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1073\/pnas.0701152104","article-title":"Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia","volume":"104","author":"Parmar","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.04.003_bib48","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1349-7006.2009.01177.x","article-title":"Cancer stem cells and their niche","volume":"100","author":"Iwasaki","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bcp.2010.04.003_bib49","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.04.003_bib50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib51","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1073\/pnas.0703478104","article-title":"Phenotypic characterization of human colorectal cancer stem cells","volume":"104","author":"Dalerba","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.04.003_bib52","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib54","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V91.7.2406","article-title":"High level engraftment of NOD\/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase","volume":"91","author":"Wang","year":"1998","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2010.04.003_bib55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/10428199309047894","article-title":"The biology of normal and neoplastic stem cells in CML","volume":"11","author":"Eaves","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.04.003_bib56","doi-asserted-by":"crossref","DOI":"10.1007\/s12185-009-0392-4","article-title":"Long-term culture of leukemic bone marrow primary cells in biomimetic osteoblast niche","author":"Hou","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib57","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells","volume":"12","author":"Krause","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/10428190801923212","article-title":"Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia","volume":"49","author":"Valent","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.04.003_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib60","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.leu.2404638","article-title":"Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells","volume":"21","author":"Brendel","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib61","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/sj.clpt.6100268","article-title":"Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia","volume":"83","author":"Wang","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2010.04.003_bib63","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bbrc.2004.08.169","article-title":"Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia","volume":"323","author":"Sorel","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2010.04.003_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/shem.2003.50046","article-title":"Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment","volume":"40","author":"Roche-Lestienne","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib65","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2004-03-1114","article-title":"Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment","volume":"105","author":"Chu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib66","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib67","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/asheducation-2008.1.436","article-title":"Chronic myeloid leukemia stem cells","author":"Jamieson","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bcp.2010.04.003_bib68","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","article-title":"A role for Wnt signalling in self-renewal of haematopoietic stem cells","volume":"423","author":"Reya","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib69","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.exphem.2004.08.012","article-title":"Molecular pathways regulating the self-renewal of hematopoietic stem cells","volume":"32","author":"Stein","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib70","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte\u2013macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib71","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.leu.2404657","article-title":"Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression","volume":"21","author":"Sengupta","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib72","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib73","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.leu.2403724","article-title":"Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli","volume":"19","author":"Holtz","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib74","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/nature02060","article-title":"Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation","volume":"425","author":"Molofsky","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib75","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01587","article-title":"Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells","volume":"423","author":"Park","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib76","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1158\/0008-5472.CAN-05-3699","article-title":"Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses","volume":"66","author":"Giafis","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib77","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm1388","article-title":"Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells","volume":"12","author":"Ito","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib78","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10428190500272507","article-title":"Detection of molecular targets on the surface of CD34+\/CD38\u2212 stem cells in various myeloid malignancies","volume":"47","author":"Florian","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.04.003_bib79","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","article-title":"Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation","volume":"14","author":"Dierks","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2010.04.003_bib80","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2003-04-1271","article-title":"BCR\/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells","volume":"103","author":"Chu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib81","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1091\/mbc.E02-10-0653","article-title":"p38 Mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest","volume":"14","author":"Deacon","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2010.04.003_bib82","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cncr.24066","article-title":"Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase","volume":"115","author":"Kantarjian","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2010.04.003_bib83","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1200\/JCO.2009.25.3724","volume":"28","author":"Cortes","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2010.04.003_bib84","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1158\/1078-0432.CCR-04-2601","article-title":"AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia","volume":"11","author":"Golemovic","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib85","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2010.04.003_bib86","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.leu.2404318","article-title":"Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib87","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","article-title":"Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis","volume":"102","author":"Branford","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib89","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1182\/blood-2008-04-149948","article-title":"Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors","volume":"112","author":"Jabbour","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib90","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1158\/1078-0432.CCR-06-1516","article-title":"Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia","volume":"12","author":"Soverini","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib91","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2006-05-025049","article-title":"MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation","volume":"109","author":"Giles","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib92","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1182\/blood-2007-09-113175","article-title":"Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I","volume":"111","author":"Gontarewicz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib93","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/0008-5472.CAN-08-3953","article-title":"Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations","volume":"69","author":"Seeliger","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib94","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.6004\/jnccn.2009.0066","article-title":"New agents in the treatment of chronic myelogenous leukemia","volume":"7","author":"Pinilla-Ibarz","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.bcp.2010.04.003_bib95","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib96","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.leu.2403257","article-title":"P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate","volume":"18","author":"Illmer","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib97","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","article-title":"Active transport of imatinib into and out of cells: implications for drug resistance","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib98","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-07-5095","article-title":"Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications","volume":"14","author":"Hiwase","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib99","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1182\/blood-2005-11-4687","article-title":"OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib","volume":"108","author":"White","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.2005.05606.x","article-title":"Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors","volume":"130","author":"Angstreich","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib101","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI117473","article-title":"Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies","volume":"94","author":"Talpaz","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2010.04.003_bib102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib103","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.beha.2009.05.002","article-title":"Current role of stem cell transplantation in chronic myeloid leukaemia","volume":"22","author":"Gratwohl","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib104","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1749-6632.1995.tb31044.x","article-title":"Biology of bone marrow stroma","volume":"770","author":"Clark","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2010.04.003_bib105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/1040-8428(94)90071-X","article-title":"Role of bone marrow matrix in normal and abnormal hematopoiesis","volume":"16","author":"Verfaillie","year":"1994","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib106","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.blre.2005.11.002","article-title":"The role of mesenchymal stem cells in haemopoiesis","volume":"20","author":"Dazzi","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.bcp.2010.04.003_bib107","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib108","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.gt.3301934","article-title":"Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo","volume":"10","author":"Al-Khaldi","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.bcp.2010.04.003_bib109","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.04.003_bib110","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.V98.9.2615","article-title":"Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells","volume":"98","author":"Reyes","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib111","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bcp.2010.04.003_bib112","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/10428190500215076","article-title":"Bone marrow-derived mesenchymal stem cells","volume":"46","author":"Kemp","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.04.003_bib113","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2008.06.004","article-title":"Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells","volume":"69","author":"Roorda","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib114","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0168-9525(03)00176-8","article-title":"Transcriptional mechanisms in osteoblast differentiation and bone formation","volume":"19","author":"Nakashima","year":"2003","journal-title":"Trends Genet"},{"key":"10.1016\/j.bcp.2010.04.003_bib115","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1101\/gad.14.11.1293","article-title":"Transcriptional regulation of adipogenesis","volume":"14","author":"Rosen","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2010.04.003_bib116","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1110955","article-title":"TAZ, a transcriptional modulator of mesenchymal stem cell differentiation","volume":"309","author":"Hong","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.04.003_bib117","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/152581600750062264","article-title":"Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages","volume":"9","author":"Majumdar","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7","article-title":"Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells","volume":"176","author":"Majumdar","year":"1998","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2010.04.003_bib119","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/33340","article-title":"Chemokines and leukocyte traffic","volume":"392","author":"Baggiolini","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib120","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0301-472X(00)00482-3","article-title":"Mesenchymal stem cells: biology and potential clinical uses","volume":"28","author":"Deans","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.1705","article-title":"CD10+ stromal cells form B-lymphocyte maturation niches in the human bone marrow","volume":"205","author":"Torlakovic","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.bcp.2010.04.003_bib122","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.0105-2896.2004.0103.x","article-title":"Mechanisms of selection mediated by interleukin-7, the preBCR, and hemokinin-1 during B-cell development","volume":"197","author":"Milne","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2010.04.003_bib123","first-page":"386","article-title":"Selective adhesion of immature thymocytes to bone marrow stromal cells: relevance to T cell lymphopoiesis","volume":"24","author":"Barda-Saad","year":"1996","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2005.01.008","article-title":"Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells","volume":"22","author":"Mazo","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2010.04.003_bib125","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib126","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bcp.2010.04.003_bib127","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib128","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","article-title":"Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide","volume":"101","author":"Krampera","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib129","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","article-title":"Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals","volume":"102","author":"Djouad","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib130","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2010.04.003_bib131","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib132","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib133","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/03008200802143190","article-title":"Extracellular matrix: a matter of life and death","volume":"49","author":"Marastoni","year":"2008","journal-title":"Connect Tissue Res"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2010.04.003_bib134","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","article-title":"Anoikis","volume":"12","author":"Gilmore","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bcp.2010.04.003_bib135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(87)90233-9","article-title":"Integrins: a family of cell surface receptors","volume":"48","author":"Hynes","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.04.003_bib136","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2007-03-080077","article-title":"Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signaling","volume":"110","author":"Zhu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib137","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.25.022106.141618","article-title":"Structural basis of integrin regulation and signaling","volume":"25","author":"Luo","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2010.04.003_bib138","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bcp.2010.04.003_bib139","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1182\/blood.V85.12.3636.bloodjournal85123636","article-title":"Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages","volume":"85","author":"Bhatia","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib140","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.04.003_bib141","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/382833a0","article-title":"The CXC chemokine SDF-1 is the ligand for LESTR\/fusin and prevents infection by T-cell-line-adapted HIV-1","volume":"382","author":"Oberlin","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.04.003_bib142","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.283.5403.845","article-title":"Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4","volume":"283","author":"Peled","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.04.003_bib143","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2009.017178","article-title":"Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4\/CXCL12 axis","author":"Vianello","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2010.04.003_bib144","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1101\/gad.1588607","article-title":"Cytokine-dependent imatinib resistance in mouse BCR-ABL+Arf-null lymphoblastic leukemia","volume":"21","author":"Williams","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2010.04.003_bib145","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1158\/1535-7163.MCT-08-0314","article-title":"Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance","volume":"7","author":"Bewry","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2010.04.003_bib146","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1182\/blood-2006-08-040022","article-title":"Adaptive secretion of granulocyte\u2013macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR\/ABL+ progenitors via JAK-2\/STAT-5 pathway activation","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib147","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Damiano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib148","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/10428190009060320","article-title":"Integrin-mediated drug resistance in multiple myeloma","volume":"38","author":"Damiano","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.04.003_bib149","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/9511","article-title":"Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo","volume":"5","author":"Sethi","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2010.04.003_bib150","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.leu.2402179","article-title":"Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR\/ABL inhibition, cytotoxic drugs, and gamma-irradiation","volume":"15","author":"Damiano","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib151","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V87.6.2450.bloodjournal8762450","article-title":"Activation-dependent alpha5beta1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells","volume":"87","author":"Lundell","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib152","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.2006.06435.x","article-title":"Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells","volume":"136","author":"Hazlehurst","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2010.04.003_bib153","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1038\/sj.onc.1206792","article-title":"Phosphorylation of Bim-EL by Erk1\/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function","volume":"22","author":"Luciano","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.04.003_bib154","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/MCB.24.14.6172-6183.2004","article-title":"Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors","volume":"24","author":"Kuribara","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.04.003_bib155","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.leu.2403898","article-title":"Compensatory PI3-kinase\/Akt\/mTor activation regulates imatinib resistance development","volume":"19","author":"Burchert","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib156","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin","volume":"100","author":"Mayerhofer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib157","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/sj.leu.2403848","article-title":"Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib","volume":"19","author":"Dengler","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib158","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood-2002-07-1973","article-title":"Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies","volume":"101","author":"Cortes","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib159","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/cncr.23006","article-title":"Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure","volume":"110","author":"Cortes","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2010.04.003_bib160","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood.V97.5.1404","article-title":"Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR\/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia","volume":"97","author":"Peters","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib161","first-page":"188","article-title":"Pharmacologic mitogen-activated protein\/extracellular signal-regulated kinase kinase\/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr\/Abl-expressing human leukemia cells","volume":"62","author":"Yu","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib162","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/blood-2006-09-045039","article-title":"MEK1\/2 inhibitors sensitize Bcr\/Abl+ human leukemia cells to the dual Abl\/Src inhibitor BMS-354\/825","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib163","first-page":"1799","article-title":"Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts","volume":"61","author":"Nimmanapalli","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib164","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.leu.2403764","article-title":"Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL\u2014inhibition of P-glycoprotein function by 17-AAG","volume":"19","author":"Radujkovic","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.04.003_bib165","first-page":"853","article-title":"The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr\/Abl-positive cell lines sensitive and resistant to imatinib mesylate","volume":"88","author":"Gatto","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2010.04.003_bib166","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2002-08-2675","article-title":"Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells","volume":"101","author":"Nimmanapalli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib167","first-page":"2118","article-title":"Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr\/Abl+ human myeloid leukemia cells","volume":"63","author":"Yu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib168","first-page":"2976","article-title":"Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells","volume":"8","author":"Yu","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2010.04.003_bib169","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2005-11-4639","article-title":"Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells","volume":"108","author":"Fiskus","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/cncr.21725","article-title":"Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells","volume":"106","author":"Morotti","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2010.04.003_bib171","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1080\/10428190903150847","article-title":"Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib","volume":"50","author":"Dillmann","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.04.003_bib172","doi-asserted-by":"crossref","first-page":"12804","DOI":"10.1073\/pnas.96.22.12804","article-title":"Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia","volume":"96","author":"Jiang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.04.003_bib173","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829","article-title":"Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte\u2013macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia","volume":"92","author":"Zhang","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.04.003_bib174","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210002480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210002480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T19:13:57Z","timestamp":1685560437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210002480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":174,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0006295210002480"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.04.003","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}